Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Journal of Cancer Survivorship
Published in: Journal of Cancer Survivorship 5/2017

01-10-2017 | Review

A systematic review of patient perspectives on surveillance after colorectal cancer treatment

Authors: Julia R . Berian, Amanda Cuddy, Amanda B. Francescatti, Linda O’Dwyer, Y. Nancy You, Robert J. Volk, George J. Chang

Published in: Journal of Cancer Survivorship | Issue 5/2017

Login to get access

Abstract

Purpose

Surveillance after colorectal cancer (CRC) treatment is routine, but intensive follow-up may offer little-to-no overall survival benefit. Given the growing population of CRC survivors, we aimed to systematically evaluate the literature for the patient perspective on two questions: (1) How do CRC patients perceive routine surveillance following curative treatment and what do they expect to gain from their surveillance testing or visits? (2) Which providers (specialists, nursing, primary care) are preferred by CRC survivors to guide post-treatment surveillance?

Methods

Systematic searches of PubMed MEDLINE, Embase, the CENTRAL Register of Controlled Trials, CINAHL, and PsycINFO were conducted. Studies were screened for inclusion by two reviewers, with discrepancies adjudicated by a third reviewer. Data were abstracted and evaluated utilizing validated reporting tools (CONSORT, STROBE, CASP) appropriate to study design.

Results

Citations (3691) were screened, 91 full-text articles reviewed, and 23 studies included in the final review: 15 quantitative and 8 qualitative. Overall, 12 studies indicated CRC patients perceive routine surveillance positively, expecting to gain reassurance of continued disease suppression. Negative perceptions described in six studies included anxiety and dissatisfaction related to quality of life or psychosocial issues during follow-up. Although 5 studies supported specialist-led care, 9 studies indicated patient willingness to have follow-up with non-specialist providers (primary care or nursing).

Conclusions

Patients’ perceptions of follow-up after CRC are predominantly positive, although unmet needs included psychosocial support and quality of life.

Implications for Cancer Survivors:

Survivors perceived follow-up as reassuring, however, surveillance care should be more informative and focused on survivor-specific needs.
Literature
1.
Siegel R, Desantis C, Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin. 2014;64(2):104–17.CrossRefPubMed
2.
Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, et al. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016;66(4):271–89.CrossRefPubMed
3.
Hewitt ME, Greenfield S, Stovall E. National Cancer Policy Board (U.S.). Committee on cancer survivorship: improving care and quality of life. From cancer patient to cancer survivor : lost in transition. Washington, D.C.: National Academies Press; 2006.
4.
Steele SR, Chang GJ, Hendren S, Weiser M, Irani J, Buie WD, et al. Practice guideline for the surveillance of patients after curative treatment of colon and rectal cancer. Dis Colon rectum. 2015;58(8):713–25.
5.
Rex DK, Kahi CJ, Levin B, Smith RA, Bond JH, Brooks D, et al. Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and US multi-society task force on colorectal cancer. CA Cancer J Clin. 2006;56(3):160–7. quiz 85-6 CrossRefPubMed
6.
Figueredo A, Rumble RB, Maroun J, Earle CC, Cummings B, McLeod R, et al. Follow-up of patients with curatively resected colorectal cancer: a practice guideline. BMC Cancer. 2003;3:26.CrossRefPubMedPubMedCentral
7.
Meyerhardt JA, Mangu PB, Flynn PJ, Korde L, Loprinzi CL, Minsky BD, et al. Follow-up care, surveillance protocol, and secondary prevention measures for survivors of colorectal cancer: American Society of Clinical Oncology clinical practice guideline endorsement. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 2013;31(35):4465–70.CrossRef
8.
Benson AB 3rd, Venook AP, Bekaii-Saab T, Chan E, Chen YJ, Cooper HS, et al. Colon cancer, version 3.2014. Journal of the National Comprehensive Cancer Network : JNCCN. 2014;12(7):1028–59.CrossRefPubMed
9.
Benson AB 3rd, Venook AP, Bekaii-Saab T, Chan E, Chen YJ, Cooper HS, et al. Rectal cancer, version 2.2015. Journal of the National Comprehensive Cancer Network : JNCCN. 2015;13(6):719–28. quiz 28 CrossRefPubMed
10.
Carpentier MY, Vernon SW, Bartholomew LK, Murphy CC, Bluethmann SM. Receipt of recommended surveillance among colorectal cancer survivors: a systematic review. J Cancer Surviv. 2013;7(3):464–83.CrossRefPubMedPubMedCentral
11.
Salloum RG, Hornbrook MC, Fishman PA, Ritzwoller DP, O’Keeffe Rossetti MC, Elston LJ. Adherence to surveillance care guidelines after breast and colorectal cancer treatment with curative intent. Cancer. 2012;118(22):5644–51.CrossRefPubMedPubMedCentral
12.
Bailey CE, Hu CY, You YN, Kaur H, Ernst RD, Chang GJ. Variation in positron emission tomography use after colon cancer resection. J Oncol Pract. 2015;11(3):e363–72.CrossRefPubMedPubMedCentral
13.
Gill S, Loprinzi CL, Sargent DJ, Thome SD, Alberts SR, Haller DG, et al. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 2004;22(10):1797–806.CrossRef
14.
Sargent DJ, Wieand HS, Haller DG, Gray R, Benedetti JK, Buyse M, et al. Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 2005;23(34):8664–70.CrossRef
15.
Tjandra JJ, Chan MK. Follow-up after curative resection of colorectal cancer: a meta-analysis. Dis Colon rectum. 2007;50(11):1783–99.
16.
Jeffery M, Hickey BE, Hider PN, See AM. Follow-up strategies for patients treated for non-metastatic colorectal cancer. The Cochrane Database of Systematic Reviews. 2016;11:CD002200.PubMed
17.
18.
19.
Arora NK, Reeve BB, Hays RD, Clauser SB, Oakley-Girvan I. Assessment of quality of cancer-related follow-up care from the cancer survivor’s perspective. J Clin Oncol. 2011;29(10):1280–9.CrossRefPubMedPubMedCentral
20.
Baravelli C, Krishnasamy M, Pezaro C, Schofield P, Lotfi-Jam K, Rogers M, et al. The views of bowel cancer survivors and health care professionals regarding survivorship care plans and post treatment follow up. J Cancer Surviv. 2009;3(2):99–108.CrossRefPubMed
21.
Beaver K, Latif S, Williamson S, Procter D, Sheridan J, Heath J, et al. An exploratory study of the follow-up care needs of patients treated for colorectal cancer. J Clin Nurs. 2010;19(23–24):3291–300.CrossRefPubMed
22.
Beaver K, Wilson C, Procter D, Sheridan J, Towers G, Heath J, et al. Colorectal cancer follow-up: patient satisfaction and amenability to telephone after care. Eur J Oncol Nurs. 2011;15(1):23–30.CrossRefPubMed
23.
Browne S, Dowie A, Mitchell E, Wyke S, Ziebland S, Campbell N, et al. Patients’ needs following colorectal cancer diagnosis: where does primary care fit in? The British Journal of General Practice : the Journal of the Royal College of General Practitioners. 2011;61(592):e692–9.CrossRef
24.
Cardella J, Coburn NG, Gagliardi A, Maier BA, Greco E, Last L, et al. Compliance, attitudes and barriers to post-operative colorectal cancer follow-up. J Eval Clin Pract. 2008;14(3):407–15.CrossRefPubMed
25.
Di Fabio F, Koller M, Nascimbeni R, Talarico C, Salerni B. Long-term outcome after colorectal cancer resection. Patients’ self-reported quality of life, sexual dysfunction and surgeons’ awareness of patients’ needs. Tumori. 2008;94(1):30–5.CrossRefPubMed
26.
Gall CA, Weller D, Esterman A, Pilotto L, McGorm K, Hammett Z, et al. Patient satisfaction and health-related quality of life after treatment for colon cancer. Dis Colon rectum. 2007;50(6):801–9.
27.
Hall SJ, Samuel LM, Murchie P. Toward shared care for people with cancer: developing the model with patients and GPs. Fam Pract. 2011;28(5):554–64.CrossRefPubMed
28.
Kjeldsen BJ, Thorsen H, Whalley D, Kronborg O. Influence of follow-up on health-related quality of life after radical surgery for colorectal cancer. Scand J Gastroenterol. 1999;34(5):509–15.CrossRefPubMed
29.
Li Destri G, Sapienza S, Rodolico M, Di Cataldo A, Puleo S, Minutolo V, et al. Stress of routine follow-up in colorectal cancer operated patients. Chir Ital. 2000;52(6):695–8.PubMed
30.
Miedema B, MacDonald I, Tatemichi S. Cancer follow-up care: patients’ perspective. Can Fam Physician. 2003;49:890–5.PubMedPubMedCentral
31.
Papagrigoriadis S, Heyman B. Patients’ views on follow up of colorectal cancer: implications for risk communication and decision making. Postgrad med J. 2003;79(933):403–7.CrossRefPubMedPubMedCentral
32.
Pisu M, Holt CL, Brown-Galvan A, Fairley T, Smith JL, White A, et al. Surveillance instructions and knowledge among African American colorectal cancer survivors. J Oncol Pract. 2014;10(2):e45–50.CrossRefPubMedPubMedCentral
33.
Rozmovits L, Rose P, Ziebland S. In the absence of evidence, who chooses? A qualitative study of patients’ needs after treatment for colorectal cancer. J Health Serv res Policy. 2004;9(3):159–64.CrossRefPubMed
34.
Steele N, Haigh R, Knowles G, Mackean M. Carcinoembryonic antigen (CEA) testing in colorectal cancer follow up: what do patients think? Postgrad med J. 2007;83(983):612–4.CrossRefPubMedPubMedCentral
35.
Sterba KR, Zapka J, LaPelle N, Armeson K, Ford ME. A formative study of colon cancer surveillance care: implications for survivor-centered interventions. Journal of cancer education : the official journal of the American Association for Cancer Education. 2014.
36.
Stiggelbout AM, de Haes JC, Vree R, van de Velde CJ, Bruijninckx CM, van Groningen K, et al. Follow-up of colorectal cancer patients: quality of life and attitudes towards follow-up. Br J Cancer. 1997;75(6):914–20.CrossRefPubMedPubMedCentral
37.
Strand E, Nygren I, Bergkvist L, Smedh K. Nurse or surgeon follow-up after rectal cancer: a randomized trial. Color dis. 2011;13(9):999–1003.CrossRef
38.
Taylor C, Richardson A, Cowley S. Surviving cancer treatment: an investigation of the experience of fear about, and monitoring for, recurrence in patients following treatment for colorectal cancer. Eur J Oncol Nurs. 2011;15(3):243–9.CrossRefPubMed
39.
Urquhart R, Folkes A, Babineau J, Grunfeld E. Views of breast and colorectal cancer survivors on their routine follow-up care. Curr Oncol. 2012;19(6):294–301.CrossRefPubMedPubMedCentral
40.
Wattchow DA, Weller DP, Esterman A, Pilotto LS, McGorm K, Hammett Z, et al. General practice vs surgical-based follow-up for patients with colon cancer: randomised controlled trial. Br J Cancer. 2006;94(8):1116–21.CrossRefPubMedPubMedCentral
41.
Wind J, Duineveld LA, van der Heijden RP, van Asselt KM, Bemelman WA, van Weert HC. Follow-up after colon cancer treatment in the Netherlands; a survey of patients, GPs, and colorectal surgeons. European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2013;39(8):837–43.CrossRef
42.
National Institute for Clinical Excellence: Improving outcomes in colorectal cancers, Manual Update(2004).
43.
Ristovski-Slijepcevic S. Environmental scan of cancer survivorship in Canada: conceptualization, practice and research. In: Agency BC, editor. Vancouver, BC2008.
44.
Zapka J, Sterba KR, LaPelle N, Armeson K, Burshell DR, Ford ME. Physician perspectives on colorectal cancer surveillance care in a changing environment. Qual Health res. 2015;25(6):831–44.CrossRefPubMedPubMedCentral
45.
Earle CC, Grunfeld E, Coyle D, Cripps MC, Stern HS. Cancer physicians’ attitudes toward colorectal cancer follow-up. Annals of Oncology : Official Journal of the European Society for Medical Oncology / ESMO. 2003;14(3):400–5.CrossRef
46.
Forsythe LP, Alfano CM, Leach CR, Ganz PA, Stefanek ME, Rowland JH. Who provides psychosocial follow-up care for post-treatment cancer survivors? A survey of medical oncologists and primary care physicians. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 2012;30(23):2897–905.CrossRef
47.
Chang GJ, Hu CY, Eng C, Skibber JM, Rodriguez-Bigas MA. Practical application of a calculator for conditional survival in colon cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 2009;27(35):5938–43.CrossRef
48.
Bowles TL, Hu CY, You NY, Skibber JM, Rodriguez-Bigas MA, Chang GJ. An individualized conditional survival calculator for patients with rectal cancer. Dis Colon rectum. 2013;56(5):551–9.
49.
Deimling GT, Bowman KF, Sterns S, Wagner LJ, Kahana B. Cancer-related health worries and psychological distress among older adult, long-term cancer survivors. Psychooncology. 2006;15(4):306–20.CrossRefPubMed
50.
Stark D, Kiely M, Smith A, Velikova G, House A, Selby P. Anxiety disorders in cancer patients: their nature, associations, and relation to quality of life. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 2002;20(14):3137–48.CrossRef
51.
Le D, Holt CL, Pisu M, Brown-Galvan A, Fairley TL, Lee Smith J, et al. The role of social support in posttreatment surveillance among African American survivors of colorectal cancer. J Psychosoc Oncol. 2014;32(3):245–63.CrossRefPubMedPubMedCentral
52.
Giese-Davis J, Collie K, Rancourt KM, Neri E, Kraemer HC, Spiegel D. Decrease in depression symptoms is associated with longer survival in patients with metastatic breast cancer: a secondary analysis. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 2011;29(4):413–20.CrossRef
53.
54.
Satin JR, Linden W, Phillips MJ. Depression as a predictor of disease progression and mortality in cancer patients: a meta-analysis. Cancer. 2009;115(22):5349–61.CrossRefPubMed
55.
Hewitt M, Ganz PA, Institute of Medicine. Implementing cancer survivorship care planning. Washington, DC: The National Academies Press; 2007. p. 320.
56.
McDowell ME, Occhipinti S, Ferguson M, Dunn J, Chambers SK. Predictors of change in unmet supportive care needs in cancer. Psychooncology. 2010;19(5):508–16.CrossRefPubMed
57.
Jacobsen PB. Clinical practice guidelines for the psychosocial care of cancer survivors: current status and future prospects. Cancer. 2009;115(18 Suppl):4419–29.CrossRefPubMed
58.
Campbell M, Fitzpatrick R, Haines A, Kinmonth AL, Sandercock P, Spiegelhalter D, et al. Framework for design and evaluation of complex interventions to improve health. BMJ. 2000;321(7262):694–6.CrossRefPubMedPubMedCentral
59.
Dixon-Woods M, Fitzpatrick R, Roberts K. Including qualitative research in systematic reviews: opportunities and problems. J Eval Clin Pract. 2001;7(2):125–33.CrossRefPubMed
60.
Metadata
Title
A systematic review of patient perspectives on surveillance after colorectal cancer treatment
Authors
Julia R . Berian
Amanda Cuddy
Amanda B. Francescatti
Linda O’Dwyer
Y. Nancy You
Robert J. Volk
George J. Chang
Publication date
01-10-2017
Publisher
Springer US
Published in
Journal of Cancer Survivorship / Issue 5/2017
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-017-0623-2

Other articles of this Issue 5/2017

Journal of Cancer Survivorship 5/2017 Go to the issue

OriginalPaper

The pervasive nature of uncertainty—a qualitative study of patients with advanced cancer and their informal caregivers

OriginalPaper

Associations between treatment, scoliosis, pulmonary function, and physical performance in long-term survivors of sarcoma

OriginalPaper

Impact of depression treatment on health-related quality of life among adults with cancer and depression: a population-level analysis

Review

Exercise for improving bone health in women treated for stages I–III breast cancer: a systematic review and meta-analyses

OriginalPaper

Outcomes of preexisting diabetes mellitus in breast, colorectal, and prostate cancer

OriginalPaper

Specialized survivor clinic attendance increases adherence to cardiomyopathy screening guidelines in adult survivors of childhood cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits